phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

MedMon_Catalyst_Banner-2.jpg

Getting back into the swing of things as Fall approaches? Here’s some light Medicare reading! And if you need a refresher, you can go back to our ABC (and Ds) of Medicare post:

  • More than 40 million:  Millions of Americans are enrolled in Medicare Part D today, helping them access the prescription medicines they need.
  • More than 700 plans: Nationwide, Part D beneficiaries have more than 700 prescription drug plans to choose from in 2017. The vast number of plan options helps beneficiaries find one that works best for them.
  • $33.50: In August, the Centers for Medicare & Medicaid Services (CMS) announced that the average monthly Part D premium in 2018 will be $33.50, about a dollar less than this year’s average.
  • 3 years: One study has found that life expectancy for beneficiaries has increased by 3.3 years since the implementation of Part D. And another recent study found that mortality rates for the elderly have decreased every year since the Part D program was implemented in 2006. 
  • 87 percent: The latest Medicare Trustees report found that the generic utilization rate among Part D beneficiaries increased again with 87 percent of all prescriptions dispensed being generic.

Want to learn more? Visit PhRMA.org/PartD.

Nicole Longo

Nicole Longo is Deputy Vice President of public affairs at PhRMA focusing on Medicare, 340B, importation and more. She previously worked for a D.C.-based public affairs firm where she assisted a wide range of clients with communications efforts on everything from trade policy to agriculture policy to health care policy. Outside the office, Nicole can be found trying new restaurants (usually Italian), taking an occasional barre class and cheering on the Cincinnati Bengals.

Nicole Longo

Author Twitter

Author LinkedIn

What AARP isn’t telling seniors about MFN

August 24, 2026

CMS proposal could discourage patient-centered innovation

August 18, 2026

Nearly 1 in 4 patients initially denied access to IRA medicines

August 6, 2026

Medicare Part D at 20: Building on a strong foundation

July 23, 2026

Medicare Monday: Medicare Part D by the numbers

Medicare Monday

Medicare

Part D

Medicare Monday: Medicare Part D by the numbers

September 11, 2017

Medicare Monday: Medicare Part D by the numbers

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list